human granulocyte colony stimulating factor

Ukraine

Drugs containing this active substance

  • GRASTIM

    It is used to reduce the duration and frequency of neutropenia (a decrease in neutrophil levels) in patients undergoing chemotherapy or bone marrow transplantation. It is also used for hematopoietic stem cell mobilization, the treatment of persistent neutropenia in HIV infection, and in certain hereditary disorders.

    Form: solution for injection

    Active substance Dosage
    human granulocyte colony stimulating factor 0.3 mg/ml

    ATC: L03AA02

    Manufacturer: Dr. Reddy's Laboratories Ltd